Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 May;47(5):1541-1553.
doi: 10.1002/hed.28132. Epub 2025 Mar 18.

Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta-Analysis

Luccas Lavareze  1   2 , Talita de Carvalho Kimura  1   2 , Nádia Cacita  2 , Reydson Alcides de Lima-Souza  1   2 , Marcelo Elias Schempf Cattan  2 , Erika Said Abu Egal  2   3 , Albina Altemani  2 , Fernanda Viviane Mariano  2
Affiliations
Meta-Analysis

Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta-Analysis

Luccas Lavareze et al. Head Neck. 2025 May.

Abstract

Background: Adenoid cystic carcinoma (ACC) is a slow-growing tumor with variable outcomes, making follow-up protocols challenging. This review analyzed outcomes in ACC, focusing on patterns and factors related to adverse prognoses.

Methods: A search was conducted on March 25, 2024, in MEDLINE, PubMed, Scopus, and EMBASE. Studies analyzing ACC survival were included, while those lacking these data or focusing on a single ACC site were excluded. The Joanna Briggs Institute's Critical Appraisal tool was used to assess the risk of bias, and the metanalysis was performed using R software.

Results: Among 57 studies (17 497 patients), ACC predominantly affected women (mean age: 52.69 years) and occurred mainly in minor salivary glands. Distant metastasis was the most frequent adverse outcome, occurring at 34.8 months on average. Locoregional metastasis and local recurrence occurred at 27.5 and 31.3 months, respectively. Five-, 10-, 15-, and 20-year survival rates were 73.8%, 48.5%, 42.3%, and 26.5%, respectively. Poor survival predictors included advanced T stage, positive lymph nodes, solid tumors, distant metastasis, and positive surgical margins.

Conclusions: Distant metastasis is the most frequent adverse outcome in ACC, and prognostic factors are related to advanced and residual tumors.

Keywords: adenoid cystic carcinoma; head and neck cancer; outcome; prognosis; salivary gland tumors.

PubMed Disclaimer

References

    1. M. Westergaard‐Nielsen, C. Godballe, J. G. Eriksen, et al., “Salivary Gland Carcinoma in Denmark: A National Update and Follow‐Up on Incidence, Histology, and Outcome,” European Archives of Oto‐Rhino‐Laryngology 278, no. 4 (2021): 1179–1188, https://doi.org/10.1007/s00405‐020‐06205‐2.
    1. WHO Classification of Head and Neck Tumours, [Internet], 5th ed. (International Agency for Research on Cancer, 2022).
    1. L. Lorini, L. Ardighieri, A. Bozzola, et al., “Prognosis and Management of Recurrent and/or Metastatic Head and Neck Adenoid Cystic Carcinoma,” Oral Oncology 115 (2021): 105213, https://doi.org/10.1016/j.oraloncology.2021.105213.
    1. E. Saleh and A. Ukwas, “Adenoid Cystic Carcinoma of Salivary Glands: A Ten‐Year Review and an Assessment of the Current Management, Surgery, Radiotherapy, and Chemotherapy,” International Journal of Otolaryngology 2023 (2023): 1–16, https://doi.org/10.1155/2023/7401458.
    1. M. J. Page, J. E. McKenzie, P. M. Bossuyt, et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” BMJ 372 (2021): n71, https://doi.org/10.1136/BMJ.N71.

LinkOut - more resources